Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-03-15
2005-03-15
Cochrane Carlson, Karen (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S069100, C435S320100, C530S324000
Reexamination Certificate
active
06867189
ABSTRACT:
The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. Adipsin polypeptides have been identified that are believed to be beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, insulin resistance, diabetes, and hypertension.
REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4444887 (1984-04-01), Hoffmann
patent: 4474893 (1984-10-01), Reading
patent: 4631211 (1986-12-01), Houghten
patent: 4714681 (1987-12-01), Reading
patent: 4716111 (1987-12-01), Osband et al.
patent: 4736866 (1988-04-01), Leder et al.
patent: 4925648 (1990-05-01), Hansen et al.
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5073627 (1991-12-01), Curtis et al.
patent: 5082767 (1992-01-01), Hatfield et al.
patent: 5112946 (1992-05-01), Maione
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5223425 (1993-06-01), Flier et al.
patent: 5258498 (1993-11-01), Huston et al.
patent: 5283173 (1994-02-01), Fields et al.
patent: 5314995 (1994-05-01), Fell, Jr. et al.
patent: 5336603 (1994-08-01), Capon et al.
patent: 5359046 (1994-10-01), Capon et al.
patent: 5403484 (1995-04-01), Ladner et al.
patent: 5427908 (1995-06-01), Dower et al.
patent: 5447851 (1995-09-01), Beutler et al.
patent: 5474981 (1995-12-01), Leder et al.
patent: 5478925 (1995-12-01), Wallach et al.
patent: 5516637 (1996-05-01), Huang et al.
patent: 5530101 (1996-06-01), Queen et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5571698 (1996-11-01), Ladner et al.
patent: 5573920 (1996-11-01), Randle
patent: 5580717 (1996-12-01), Dower et al.
patent: 5580734 (1996-12-01), Treco et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5601819 (1997-02-01), Wong et al.
patent: 5605793 (1997-02-01), Stemmer
patent: 5608426 (1997-03-01), Hester
patent: 5622929 (1997-04-01), Willner et al.
patent: 5641670 (1997-06-01), Treco et al.
patent: 5641870 (1997-06-01), Treco et al.
patent: 5658727 (1997-08-01), Barbas et al.
patent: 5667973 (1997-09-01), Fields et al.
patent: 5733734 (1998-03-01), Trojanowski et al.
patent: 5733761 (1998-03-01), Treco et al.
patent: 5750753 (1998-05-01), Kimae et al.
patent: 5780225 (1998-07-01), Wigler et al.
patent: 5783385 (1998-07-01), Treco et al.
patent: 5807715 (1998-09-01), Morrison et al.
patent: 5811097 (1998-09-01), Allison et al.
patent: 5811238 (1998-09-01), Stemmer et al.
patent: 5814318 (1998-09-01), Lonberg et al.
patent: 5817789 (1998-10-01), Heartlein et al.
patent: 5821047 (1998-10-01), Garrard et al.
patent: 5834252 (1998-11-01), Stemmer et al.
patent: 5837458 (1998-11-01), Minshull et al.
patent: 5869239 (1999-02-01), Treco et al.
patent: 5869330 (1999-02-01), Scherer et al.
patent: 5965125 (1999-10-01), Mineau-Hanschke
patent: 5968502 (1999-10-01), Treco et al.
patent: 5994127 (1999-11-01), Selden et al.
patent: 5994616 (1999-11-01), Rosen
patent: 6013857 (2000-01-01), Deboer et al.
patent: 6048524 (2000-04-01), Selden et al.
patent: 6048724 (2000-04-01), Selden et al.
patent: 6048729 (2000-04-01), Selden et al.
patent: 6054288 (2000-04-01), Selden et al.
patent: 6140552 (2000-10-01), Deboer et al.
patent: 20030170630 (2003-01-01), Alsobrook, II et al.
patent: 20030212256 (2003-02-01), Ediger et al.
patent: 0 036 776 (1981-09-01), None
patent: 0 239 400 (1987-09-01), None
patent: 0 307 434 (1989-03-01), None
patent: 0 367 166 (1990-05-01), None
patent: 0 394 827 (1990-10-01), None
patent: 0 396 387 (1990-11-01), None
patent: 0 401 384 (1990-12-01), None
patent: 0 439 095 (1991-07-01), None
patent: 0 519 596 (1992-12-01), None
patent: 0 572 287 (1993-12-01), None
patent: 0 592 106 (1994-04-01), None
patent: WO 8403506 (1984-09-01), None
patent: WO 8403564 (1984-09-01), None
patent: WO 8912624 (1989-12-01), None
patent: WO 9002809 (1990-03-01), None
patent: WO 9011092 (1990-10-01), None
patent: WO 9100360 (1991-01-01), None
patent: WO 9106570 (1991-05-01), None
patent: WO 9108216 (1991-06-01), None
patent: WO 9109967 (1991-07-01), None
patent: WO 9110737 (1991-07-01), None
patent: WO 9110741 (1991-07-01), None
patent: WO 9114438 (1991-10-01), None
patent: WO 9201047 (1992-01-01), None
patent: WO 9205793 (1992-04-01), None
patent: WO 9208495 (1992-05-01), None
patent: WO 9208802 (1992-05-01), None
patent: WO 9218522 (1992-10-01), None
patent: WO 9218619 (1992-10-01), None
patent: WO 9222324 (1992-12-01), None
patent: WO 9311236 (1993-06-01), None
patent: WO 9317717 (1993-09-01), None
patent: WO 9321232 (1993-10-01), None
patent: WO 9325234 (1993-12-01), None
patent: WO 9406920 (1994-03-01), None
patent: WO 9410308 (1994-05-01), None
patent: WO 9412650 (1994-06-01), None
patent: WO 9423026 (1994-10-01), None
patent: WO 9504141 (1995-02-01), None
patent: WO 9511307 (1995-04-01), None
patent: WO 9515982 (1995-06-01), None
patent: WO 9520401 (1995-08-01), None
patent: WO 9604388 (1996-02-01), None
patent: WO 9629411 (1996-09-01), None
patent: WO 9631523 (1996-10-01), None
patent: WO 9633735 (1996-10-01), None
patent: WO 9634096 (1996-10-01), None
patent: WO 9640281 (1996-12-01), None
patent: WO 9824893 (1998-06-01), None
patent: WO 9845438 (1998-10-01), None
patent: WO 9846645 (1998-10-01), None
patent: WO 9849305 (1998-11-01), None
patent: WO 9850433 (1998-11-01), None
Friedman, “Obesity in the new millenium”,Nature(2000), 404(6778):632-634.
Kopelman, “Obesity as a medical problem”,Nature(2000), 404(6778):635-643.
Barsh, et al., “Genetics of body-weight regulation”,Nature(2000), 404(6778):644-651.
Kim, S.J., “Crystal structure of a complement factor D mutant expressing enhanced catalytic activity”,J. Biol. Chem.(1995), 270(41):24399-24405.
Volanakis, J.E., “Complement factor D, a novel serine protease”,Protein Science(1996), 5:553-564.
Smith and Johnson, “Single-step purification of polypeptides expressed inEscherichia colias fusions with glutathione S-transferase”,Gene(1988), 67(1):31-40.
Bowie et al., “Deciphering the message in protein sequences: tolerance to amino acid substitutions”,Science(1990), 247:1306-1310.
Vaitukaitis, et al., “A method for producing specific antisera with small doses of immunogen”,J. Clin. Endocrinol. Metab.(1971), 33:988-991.
Zoller, et al., “Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA”,Nucl. Acids. Res.(1987), 10:6487.
Wells, et al. “Cassette mutagenesis: an efficient method for generation of mutations at defined sites”,Gene(1985), 34:315.
Wells, et al., “Importance of hydrogen-bond formation in stabilizing the transition state of subtilisin”,Philos Trans. R. Soc. London SerA(1986), 317:415.
Cunningham, et al., “High-resolution epitope mapping of hGH-recptor interactions by alanine-scanning mutagenesis”,Science(1989), 244:1081-1085.
Creighton.Proteins: Structures and Molecule Principles,W.H. Freeman Co., (2nded. 1983), T.E., NY.
Davis, et al.,Method in Molecular Biology,(ed. 1986); Elsevier Press, NY.
Pinckard, et al., “Factors influencing the immune response”,Clin. Exp. Immunol.(1967), 2:331-340.
Robbins et al., “Antibodies to covalent aggregates of insulin in blood of insulin-using diabetic patients”,Diabetes(1987), 36:838-845.
Engvall, “Enzyme Immunoassay ELISA and EMIT”,Meth. Enzymol.(1980), 70:491-439.
Pearson, et al., “Improved tools for biological sequence comparison”,Proc. Natl. Acad. Sci. USA(1988), 85(8):2444-8.
Altschul, S.F. et al., “Basic local alignment search tool”,J. Mol. Biol.(1990), 5:215(3):403-10; PMID: 223712.
Thompson, et al., “Clustal W: improving the sensitivity of progressive multiple sequence alignment through sequence weigh
Briggs Kristen
Lucas John
Carlson Karen Cochrane
Desai Anand U
Genset S.A.
Saliwanchik Lloyd & Saliwanchik
LandOfFree
Use of adipsin/complement factor D in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of adipsin/complement factor D in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of adipsin/complement factor D in the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3369949